3 Defense Stocks Riding the High-Energy Laser Boom

Rapid improvements in fiber lasers, target tracking, optics and thermal management are making high-energy laser systems increasingly viable for military and defense use. Counter-drone applications are emerging as a key near-term use case, with additional defense applications expected to follow. The article signals constructive technological progress but provides no specific contracts, financial figures, or deployment timelines.

Analysis

The investable implication is not a broad defense-spending trade: directed-energy remains a procurement-cycle and field-reliability story, with value likely accruing first to prime contractors able to integrate sensors, command-and-control, power systems, and sustainment into existing air-defense architectures. RTX, Northrop Grumman (NOC), Lockheed Martin (LMT), and General Dynamics (GD) are better positioned than pure-play laser suppliers because military customers buy a validated kill chain rather than a laser component. Initial economics favor fixed-site and naval applications, where power and cooling constraints are manageable, before mobile systems become material.

The non-obvious beneficiary is the counter-UAS ecosystem. Cheap drones are forcing a shift from high-cost interceptor missiles toward lower-cost-per-engagement layers; if directed energy proves reliable, it could pressure the long-run replenishment value of traditional short-range kinetic interceptors while expanding demand for radar, electro-optical/infrared sensors, targeting software, power electronics, and thermal-management hardware. Leidos (LDOS), RTX, NOC, and potentially Kratos (KTOS) have broader exposure to this architecture than laser manufacturers such as IPG Photonics (IPGP), nLIGHT (LASR), or Coherent (COHR), whose defense revenue exposure and qualification timelines remain too uncertain to underwrite a standalone thesis.

Near-term equity impact is likely limited because programs must clear operational testing, appropriations, and production-contract conversion; the relevant catalysts are FY27 budget submissions, named production awards, and evidence of deployed-system availability rather than laboratory performance claims. The thesis is falsified if field tests show poor performance in dust, rain, fog, or swarm saturation, or if power/thermal integration pushes system costs near kinetic alternatives. Consensus may be underestimating the eventual margin impact for primes with installed air-defense bases, but overestimating the speed at which experimental laser programs become recurring revenue.

Key Decisions for Investors

• No immediate directional trade on the article alone; establish an event-driven watchlist around RTX, NOC, LMT, GD, and LDOS for contract awards that specify production quantities, multi-year sustainment, or deployment status rather than R&D funding.
• For a 6-18 month defense-technology allocation, favor a basket long RTX/NOC/LDOS over IPGP/LASR: primes monetize the complete counter-UAS stack and can absorb certification delays, while component suppliers face customer concentration and uncertain program conversion.
• Use KTOS only as a higher-beta satellite position after verification of its role in a funded counter-UAS or directed-energy program; size smaller than primes given execution risk. Exit on a material program delay, failed operational test, or guidance that does not identify funded production revenue.
• Monitor U.S. and allied drone-interception spending, interceptor inventory drawdowns, and disclosed cost-per-shot data over the next 1-3 months. A demonstrated cost advantage versus kinetic interceptors would justify increasing exposure; absent that evidence, treat directed energy as a long-dated option rather than an earnings catalyst.